Skip to product information
1 of 1

SREBF1 Mouse mAb

SREBF1 Mouse mAb

Catalog Number: S0B60237 Application: WB, IHC-P Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen SREBF1
Synonyms Sterol regulatory element-binding protein 1; Class D basic helix-loop-helix protein 1 (bHLHd1); Sterol regulatory element-binding transcription factor 1; BHLHD1; SREBP1
Location Nucleus, Endoplasmic reticulum
Accession P36956
Antibody Type Mouse mAb
Isotype IgG1
Application WB, IHC-P
Reactivity Hu
Positive Sample Jurkat, HT-29, HeLa, MCF7, A549, HepG2
Purification Protein G
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:2000 Hu
IHC-P 1:200 Hu

Background

SREBF1 is a basic helix-loop-helix-leucine zipper transcription factor encoded by the SREBF1 gene and serves as a critical "master regulator" of lipid metabolism. In mammals, SREBF1 exists in two major isoforms—SREBP-1a and SREBP-1c—generated by distinct promoters, with SREBP-1c being predominant in metabolically active tissues such as the liver and adipose tissue, where it governs the synthesis of fatty acids and triglycerides. A unique feature of this protein is its mechanism for sensing cellular sterol levels within the endoplasmic reticulum membrane: when cholesterol is depleted, its N-terminal transcriptional active domain is released via proteolytic cleavage and translocates into the nucleus, where it binds to sterol regulatory elements in the promoters of target genes, activating the transcription of genes such as fatty acid synthase and acetyl-CoA carboxylase. Dysregulation of its function is closely associated with various metabolic diseases: hyperactivation promotes non-alcoholic fatty liver disease and insulin resistance, while variations in this gene have also been linked to traits such as obesity and dyslipidemia. Furthermore, through an interaction network with other transcription factors (such as LXR and ChREBP), this protein integrates signals from glucose and lipid metabolism to collectively maintain systemic energy homeostasis.

Picture

Western Blot

WB result of SREBF1 Mouse mAb
Primary antibody: SREBF1 Mouse mAb at 1/2000 dilution
Lane 1: Jurkat whole cell lysate 20 µg
Lane 2: HT-29 whole cell lysate 20 µg
Lane 3: HeLa whole cell lysate 20 µg
Lane 4: MCF7 whole cell lysate 20 µg
Lane 5: A549 whole cell lysate 20 µg
Lane 6: HepG2 whole cell lysate 20 µg
Secondary antibody: Goat Anti-Mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 125 kDa
Observed MW: 125 kDa

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human kidney. Anti-SREBF1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human breast cancer. Anti-SREBF1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.